Technology | November 24, 2010

Advanced Visualization Software Passes Evaluation and Testing

November 24, 2010 – A new advanced visualization and analysis software suite has passed a detailed evaluation and testing process and is now available for sale. The Vitrea Enterprise Suite version 6.0, from Vital Images, has achieved VMware Ready status and is now listed on the VMware Partner Product Catalog.

Version 6.0 provides in-depth clinical functionality via a modular architecture that delivers optimal performance and thin-client access to applications and image data.

Passing the extensive testing helps ensure that it makes best use of the company’s technology and is ready for deployment in customer environments.

“We are pleased that Vital Images qualifies for the VMware Ready logo, signifying to customers that it has passed specific VMware testing and interoperability criteria and is ready to run their mission-critical business applications and operations,” said Bernie Mills, senior director, alliance programs, VMware.

The platform separates rendering, processing and data storage to deliver sustained quality of service for clinicians regardless of the number of simultaneous users or data load. For IT departments, the platform cost-effectively scales to meet the specific imaging needs of the healthcare institution.

New clinical features extend multi-modality and oncology capabilities by introducing Dynamic MR, XA 3-D Angio and Oncology Fusion, which allows users to visualize, quantify and track tumors using fused CT, MR, PET and SPECT images. A new de-noising filter also allows users to toggle between pre- and post-filtered images “on the fly” for improved diagnostic confidence. Dynamic MR has been approved in Europe and Canada.

It also includes a new multichamber cardiovascular solution, which enables comprehensive assessment of cardiovascular function and structures for adults and pediatrics. The endovascular stent planning application has been enhanced, adding thoracic aortic aneurism (TAA) to abdominal aortic aneurism (AAA) capabilities. The existing clinical applications, user interface and automated workflows have also been enhanced to speed diagnosis, communication and collaboration for efficient, informed decision making.

For more information: www.vitalimages.com

Related Content

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC).

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC). 

Feature | Clinical Decision Support | January 18, 2018
January 18, 2018 — Change Healthcare announced the acquisition of National Decision Support Company (NDSC), a leader
Videos | Artificial Intelligence | January 18, 2018
ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence advances at the Radiological Soci
Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Imaging | January 17, 2018
January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed t
Sponsored Content | Videos | Enterprise Imaging | January 17, 2018
Mitchell Goldburgh, global solutions manager for enterprise imaging and analytics manager for NTT Data Services, form
Sponsored Content | Videos | Enterprise Imaging | January 16, 2018
Built on an over 25-year pioneering legacy in the advanced visualization industry, Vital continues to expand on three
RSNA 2017 Celebrates Innovation in Radiology
News | Imaging | January 15, 2018
January 15, 2018 — The Radiological Society of North America’s...
News | Clinical Decision Support | January 12, 2018
January 12, 2018 — GE Healthcare has entered into a strategic, long-term partnership with Roche to jointly develop an
The artificial intelligence (AI) smart algorithm onboard the Infervision stroke product calculates the volume of bleed on the basis of multiple brain CT slices.

The AI smart algorithm onboard the Infervision stroke product calculates the volume of bleed on the basis of multiple brain CT slices. The size of the bleed volume indicates the urgency and type of treatment required.

Feature | Artificial Intelligence | January 10, 2018 | Greg Freiherr
Exhibitors at the 2017 Radiological Society of North American (RSNA) meeting rode the...
Videos | Enterprise Imaging | January 09, 2018
Konica Minolta President of Healthcare IT Steve Deaton details new features in the Exa Platform designed to improve c
Toshiba Medical Systems Changes Name to Canon Medical Systems Corp.
News | Business | January 08, 2018
Canon Inc. and Canon Medical Systems Corp. announced the official corporate name (trade name) change of Canon Group...
Overlay Init